Melanie Hagen

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.

Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.

Journal: The New England journal of medicine

Published: July 29, 2026

Progress and promise of CAR-T cell treatment in autoimmune diseases.

Progress and promise of CAR-T cell treatment in autoimmune diseases.

Journal: PLoS medicine

Published: July 20, 2026

Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune disease.

Editorial-Immune reset in sight: CAR-T cell therapy in autoimmune disease.

Journal: EULAR rheumatology open

Published: June 29, 2026

Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.

Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.

Journal: EULAR rheumatology open

Published: June 29, 2026

Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.

Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.

Journal: Rheumatology (Oxford, England)

Published: April 22, 2026

The why, what, who and when of B cell depletion in systemic lupus erythematosus: biological rationale, patient stratification and evolving therapeutic modalities.

The why, what, who and when of B cell depletion in systemic lupus erythematosus: biological rationale, patient stratification and evolving therapeutic modalities.

Journal: Rheumatology (Oxford, England)

Published: March 19, 2026

Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity.

Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity.

Journal: RMD open

Published: February 03, 2026

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

Journal: Annals of the rheumatic diseases

Published: December 19, 2025

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

Journal: The New England journal of medicine

Published: October 15, 2025

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Journal: Nature medicine

Published: September 30, 2025

Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis.

Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis.

Journal: The Journal of rheumatology

Published: September 04, 2025

Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' reply.

Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' reply.

Journal: The Lancet. Rheumatology

Published: July 23, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026